Precipio, Inc. (PRPO) NASDAQ
22.53
-0.27(-1.18%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
22.53
-0.27(-1.18%)
Currency In USD
Address
4 Science Park
New Haven, CT 06511
United States of America (the)
Phone
203 787 7888
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
54
First IPO Date
June 30, 2017
| Name | Title | Pay | Year Born |
| Ilan Danieli | Founder, President, Chief Executive Officer & Director | 427,124 | 1972 |
| Ahmed Zaki Sabet | Chief Operating Officer | 274,532 | 1985 |
| Ayman Mohamed | Chief Technology Officer | 277,896 | 1984 |
| Miri Chiko-Radomski | Chief Legal Counsel & People Officer | 0 | N/A |
| Matthew Gage | Chief Financial Officer | 0 | 1967 |
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.